FDAFDA · Food and drugs·Recall number D-0923-2023
Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10
Published July 26, 2023 · Recall initiated: June 21, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr Reddy's Laboratories Limited
- Distributor
- Nationwide in the USA
- UPC
- 0355111180104
- Lot
- Lot: T2100585, T2100586, T2100587, Exp 12/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.